Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ALI CYRUS CHEHROUDI

Allopathic & Osteopathic Physicians Urology

NPI
1831877612
CMS profile
11442509
Location
ALTAMONTE SPRINGS, FL

General Payments · PY2024

$3,358.98

  • Reported across 17 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$3,358.98

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Travel and Lodging $2,354.72 7
Food and Beverage $1,004.26 10

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
BOSTON SCIENTIFIC CORPORATION $2,812.04 12
COLOPLAST CORP $176.17 1
Olympus America Inc. $145.92 1
Ambu Inc. $135.25 2
UROGEN PHARMA, INC. $89.60 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2024 $3,358.98 17

Payment records · PY2024 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2024
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Ambu Inc. $131.16 07/16/2024 Food and Beverage Undisputed 01/23/2026 1134082766 CMS
Ambu Inc. $4.09 07/26/2024 Food and Beverage Undisputed 01/23/2026 1134077160 CMS
Boston Scientific Corporation $291.64 04/11/2024 Travel and Lodging Undisputed 01/23/2026 1092499366 CMS
Boston Scientific Corporation $1,209.92 04/11/2024 Travel and Lodging Undisputed 01/23/2026 1092499372 CMS
Boston Scientific Corporation $62.36 04/12/2024 Travel and Lodging Undisputed 01/23/2026 1092499354 CMS
Boston Scientific Corporation $109.87 04/12/2024 Food and Beverage Undisputed 01/23/2026 1092499358 CMS
Boston Scientific Corporation $112.73 04/12/2024 Food and Beverage Undisputed 01/23/2026 1092499360 CMS
Boston Scientific Corporation $291.64 04/12/2024 Travel and Lodging Undisputed 01/23/2026 1092499368 CMS
Boston Scientific Corporation $31.18 04/13/2024 Travel and Lodging Undisputed 01/23/2026 1092499350 CMS
Boston Scientific Corporation $74.65 04/13/2024 Food and Beverage Undisputed 01/23/2026 1092499356 CMS
Boston Scientific Corporation $291.64 04/13/2024 Travel and Lodging Undisputed 01/23/2026 1092499370 CMS
Boston Scientific Corporation $118.00 06/13/2024 Food and Beverage Undisputed 01/23/2026 1092499362 CMS
Boston Scientific Corporation $42.07 07/18/2024 Food and Beverage Undisputed 01/23/2026 1092499352 CMS
Boston Scientific Corporation $176.34 07/18/2024 Travel and Lodging Undisputed 01/23/2026 1092499364 CMS
COLOPLAST CORP $176.17 09/12/2024 Food and Beverage Undisputed 01/23/2026 1117450062 CMS
Olympus America Inc. $145.92 05/22/2024 Food and Beverage Undisputed 01/23/2026 1108474606 CMS
UROGEN PHARMA, INC. $89.60 09/26/2024 Food and Beverage Undisputed 01/23/2026 1137919817 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2024
Source files
Dataset page · Bulk file · PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.